Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 7 | 2023 | 238 | 1.290 |
Why?
|
| Myocytes, Cardiac | 6 | 2020 | 165 | 1.110 |
Why?
|
| Nicotinic Agonists | 2 | 2019 | 68 | 0.840 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 88 | 0.700 |
Why?
|
| Stroke Volume | 1 | 2019 | 97 | 0.670 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 104 | 0.670 |
Why?
|
| Atherosclerosis | 1 | 2019 | 131 | 0.630 |
Why?
|
| Transcription Factors | 2 | 2009 | 653 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 7 | 2023 | 1530 | 0.450 |
Why?
|
| Cyclins | 2 | 2009 | 35 | 0.430 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2009 | 37 | 0.420 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 145 | 0.350 |
Why?
|
| Mice | 11 | 2023 | 5668 | 0.350 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 26 | 0.350 |
Why?
|
| Oxidative Stress | 6 | 2020 | 874 | 0.340 |
Why?
|
| Fatty Liver | 2 | 2019 | 56 | 0.320 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2007 | 12 | 0.300 |
Why?
|
| Animals | 13 | 2023 | 14307 | 0.300 |
Why?
|
| Cardiomegaly | 1 | 2007 | 39 | 0.300 |
Why?
|
| Phenotype | 2 | 2023 | 650 | 0.290 |
Why?
|
| Cotinine | 3 | 2020 | 40 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 283 | 0.260 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1300 | 0.250 |
Why?
|
| Lipolysis | 1 | 2023 | 18 | 0.240 |
Why?
|
| Mice, Obese | 2 | 2020 | 37 | 0.230 |
Why?
|
| Endoribonucleases | 1 | 2023 | 23 | 0.230 |
Why?
|
| Apoptosis | 3 | 2020 | 1317 | 0.220 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 146 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2019 | 897 | 0.200 |
Why?
|
| Cytokines | 1 | 2023 | 569 | 0.180 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 37 | 0.180 |
Why?
|
| Aerosols | 1 | 2019 | 48 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 155 | 0.170 |
Why?
|
| Heart | 1 | 2020 | 178 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 51 | 0.170 |
Why?
|
| Cyclin T | 2 | 2009 | 16 | 0.170 |
Why?
|
| Myocardium | 1 | 2020 | 224 | 0.160 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 165 | 0.160 |
Why?
|
| Benzamides | 1 | 2018 | 76 | 0.150 |
Why?
|
| Behavior, Animal | 1 | 2019 | 304 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 416 | 0.150 |
Why?
|
| Male | 8 | 2020 | 18870 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2019 | 859 | 0.130 |
Why?
|
| Mutation | 1 | 2019 | 1023 | 0.130 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2020 | 49 | 0.120 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2013 | 14 | 0.120 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2013 | 1 | 0.120 |
Why?
|
| Smoking | 1 | 2020 | 903 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 968 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 221 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2013 | 486 | 0.090 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2009 | 12 | 0.090 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 15 | 0.090 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 48 | 0.090 |
Why?
|
| RNA Polymerase II | 1 | 2009 | 24 | 0.090 |
Why?
|
| Humans | 5 | 2023 | 34853 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2018 | 1802 | 0.090 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2007 | 11 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2007 | 31 | 0.080 |
Why?
|
| RNA | 1 | 2009 | 234 | 0.080 |
Why?
|
| Blotting, Northern | 1 | 2007 | 139 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 185 | 0.070 |
Why?
|
| Palmitates | 1 | 2023 | 13 | 0.060 |
Why?
|
| Hep G2 Cells | 1 | 2023 | 52 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2023 | 118 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 39 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 143 | 0.050 |
Why?
|
| Echocardiography | 1 | 2020 | 144 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2020 | 323 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 3261 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2020 | 121 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 60 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 139 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 129 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1149 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 528 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 34 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2019 | 834 | 0.040 |
Why?
|
| Caspases | 1 | 2016 | 132 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 1503 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 14 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 32 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 15 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 878 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 126 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 60 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 642 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 109 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 161 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 286 | 0.030 |
Why?
|
| RNA Interference | 1 | 2013 | 225 | 0.030 |
Why?
|
| Mitochondria | 1 | 2013 | 454 | 0.020 |
Why?
|
| Female | 1 | 2020 | 19873 | 0.010 |
Why?
|
Espinoza-Derout's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_